Exploring Analyst Estimates for Alnylam (ALNY) Q3 Earnings, Beyond Revenue and EPS

Wall Street analysts forecast that Alnylam Pharmaceuticals (ALNY) will report quarterly earnings of $1.67 per share in its upcoming release, pointing to a year-over-year increase of 434%. It is anticipated that revenues will amount to $1.02 billion, exhibiting an increase of 104% compared to the year-ago quarter.The current level reflects an upward revision of 43.6% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively re ...